Sessions & Panelists
A perspective on R&D direction setting: Dr VK Vinayak, Industry Expert & CSO Biologicals, Panacea Biotec
Stem Cells & Gene Therapy (Trends and Policies): Dr Mrinalini Chaturvedi, Director, Cryo Banks International; Dr Alka Sharma, Jt Director, Department of Biotechnology; Dr Venkatesh Ponemone, Director, Laboratory and Clinical Research Affairs, Fortis- Totipotentrx Centrer for Cellular Medicine
Next Generation Innovation: Dr Geetha Vani Rayasam, Open Source Drug Discovery, CSIR; Dr VK Vinayak, CSO-Biologicals, Panacea Biotec; Dr Navin Khanna, Group Leader, Gene Recombinant Lab, ICGEB; Dr Alok Adholeya, Director of Biotechnology & Bioresources Division, The Energy and Resources Institute (TERI)
Bringing Technology/ Enabling Science: Dr VL Ramprasad, Chief Scientist- Genomics, Spinco
Public Private Partnerships: A case for excellence: Mr Pankaj Sharma, CEO, LeadInvent; Parul Saxena & Javed Ahmad, Jamia Hamdard Universitry Team; Dr Jitendra Verma, MD, Lifecare Innovations, Dr Ravi Dhar, Senior Consultant, BIRAP, DBT
Computer-aided Drug Discovery: Dr B Jayaram, Head-Computational Biology, IIT, Delhi; Mr Sahil Kapoor, CEO, Novo Informatics; Prof. Indira Ghosh, Dean, School of Computational and Integrative Sciences, Jawahar Lal Nehru University, Mr Pankaj Sharma, CEO, LeadInvent
BioSpectrum Technology Forum 2012 (BSTF) in Delhi saw the industry leaders getting together on the theme: “Game Changers in Drug Discovery & Development�. This was the third leg of the one-day BSTF series that brings together R&D leaders of the bioscience industry. The first two legs of the series were held in Bangalore and Mumbai, respectively. The sessions spanned diverse topics ranging from stem cells and gene therapy, to next generation innovation, public private partnerships, and computer-aided drug discovery.
The discussion on public private partnerships was an addition to the Forum agenda keeping in view the role such partnerships are playing in taking the industry further and its enormous potential. The panel discussion on “public private partnerships� was chaired by Dr Ravi Dhar, Senior Consultant, BIRAP, DBT.
The conference was opened by Dr Renu Swarup, Senior Adviser, Department of Biotechnology, who in her opening address elaborated on the BIRAP initiatives for the industry and how industry can benefit from these. Dr VK Vinayak, an industry veteran and CSO, Biologicals at Panacea Biotec, gave his perspective on the research direction the industry needs to take and also tied-up and summarized the key points from the industry. The industry leaders shared their perspective and insights across the range of topics. Many of you missed the action. However, we are not putting in a full report here, it will be available on our website, in a month or so, when the BioSpectrum new online platform goes live.
BSTF 2012 at Delhi was supported by: Department of Biotechnology, Government of India, and Spinco Biotech.
|
Nandita Singh, Editor, BioSpectrum, welcomes the panelists and delegates
|
|
Dr VK Vinayak, industry expert & CSO Biologicals, Panacea Biotec, and a panelist at the event, sets the tone for discussion
|
|
Dr Renu Swarup, Sr Advisor, DBT, gives the inaugural address
|
BSTF Panelists @ Random
|
Dr Venkatesh Ponemone, Fortis- Totipotentrx Centre for Cellular Medicine
|
|
Dr Mrinalini Chaturvedi, Cryo Banks International
|
|
Dr Alka Sharma, Department of Biotechnology
|
|
Dr Navin Khanna, Gene Recombinant Lab, ICGEB
|
|
Dr Geetha Vani Rayasam, Open Source Drug Discovery, CSIR
|
|
Dr Alok Adholeya, The Energy and Resources Institute (TERI)
|
|
Dr VL Ramprasad, Spinco
|
|
Dr Ravi Dhar, BIRAP, DBT
|
|
Jitendra Verma, Lifecare Innovations
|
|
Mr Pankaj Sharma, LeadInvent
|
|
Parul Saxena, Jamia Hamdard University
|
|
Mr Sahil Kapoor, Novo Informatics
|
|
Dr B Jayaram, IIT, Delhi
|
|
Prof Indira Ghosh, Jawahar Lal Nehru University
|